Nasdaq issues bid-price deficiency notice to Celularity (NASDAQ: CELU)
Rhea-AI Filing Summary
Celularity Inc. reported that on July 23, 2026 it received a notice from the Nasdaq Stock Market stating its Class A common stock no longer meets the $1.00 per share minimum bid price requirement under Nasdaq Listing Rule 5450(a)(1), after the closing bid stayed below that level for 30 consecutive business days.
The notice does not immediately affect trading of CELU shares on the Nasdaq Capital Market. Under Nasdaq Listing Rule 5810(c)(3)(A), Celularity has 180 calendar days, until January 19, 2027, for its closing bid price to be at least $1.00 for a minimum of 10 consecutive business days to regain compliance. The company plans to monitor its share price and evaluate options, while cautioning there is no assurance it will regain compliance, obtain a second 180-day grace period, or maintain compliance with other Nasdaq listing requirements.
Positive
- None.
Negative
- Nasdaq minimum bid deficiency: Celularity received notice that its Class A common stock closed below $1.00 for 30 consecutive business days, putting its Nasdaq Capital Market listing at risk if compliance is not restored by January 19, 2027.
8-K Event Classification
Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
1 item
Item 3.01
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Securities
The company received a delisting notice or transferred its listing to a different exchange.
Key Figures
Consecutive days below $1.00: 30 consecutive business days
Minimum bid requirement: $1.00 per share
Initial compliance period: 180 calendar days
+2 more
5 metrics
Consecutive days below $1.00
30 consecutive business days
Closing bid price under $1.00 per share triggering Nasdaq notice
Minimum bid requirement
$1.00 per share
Nasdaq Listing Rule 5450(a)(1) minimum bid price for continued listing
Initial compliance period
180 calendar days
Time allowed under Nasdaq Listing Rule 5810(c)(3)(A) to cure deficiency
Compliance deadline
January 19, 2027
End of the 180-day period to restore minimum bid price compliance
Days of required compliant trading
10 consecutive business days
Period closing bid must be at or above $1.00 to regain compliance
Key Terms
Nasdaq Listing Rule 5450(a)(1), Nasdaq Listing Rule 5810(c)(3)(A), minimum bid price requirement, market value of publicly held shares, +1 more
5 terms
Nasdaq Listing Rule 5450(a)(1) regulatory
"no longer complies with the minimum bid price requirement under Nasdaq Listing Rule 5450(a)(1)"
Nasdaq Listing Rule 5450(a)(1) is a continued-listing standard that sets a minimum share price companies must maintain to remain listed on the Nasdaq market—commonly a $1.00 per-share threshold. Investors care because falling below that floor can trigger a compliance review and possible delisting, which is like failing a minimum grade and losing access to the public market; delisting can reduce liquidity, visibility and the ability to raise capital.
Nasdaq Listing Rule 5810(c)(3)(A) regulatory
"In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has a period of 180 calendar days"
minimum bid price requirement regulatory
"no longer complies with the minimum bid price requirement for continued listing on the Nasdaq Capital Market"
A minimum bid price requirement is a rule that a stock must trade above a set price for a specified period to stay listed on an exchange. It matters to investors because falling below that threshold can trigger warnings or removal from the exchange, which can cut liquidity, reduce visibility, and often lead to sharper declines in share value—think of it like a venue’s minimum dress code that, if not met, can bar a performer from the stage.
Nasdaq Capital Market regulatory
"continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5450(a)(1)"
The Nasdaq Capital Market is a platform where smaller, emerging companies can list their shares for trading by investors. It provides these companies with access to funding and visibility, helping them grow, much like a local marketplace where new vendors can introduce their products to potential customers. For investors, it offers opportunities to discover early-stage companies with growth potential.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What Nasdaq notice did Celularity (CELU) receive on July 23, 2026?
Celularity received a Nasdaq notice that its Class A common stock no longer meets the $1.00 minimum bid price requirement after trading below $1.00 for 30 consecutive business days under Nasdaq Listing Rule 5450(a)(1).
How long does Celularity (CELU) have to regain Nasdaq bid-price compliance?
Celularity has 180 calendar days, until January 19, 2027, to regain compliance. During this period, it must restore its closing bid price to at least $1.00 per share for a required time span.
Does the Nasdaq notice immediately affect Celularity (CELU) trading on Nasdaq?
The notice has no immediate effect on Celularity’s listing. Its Class A common stock continues to trade on the Nasdaq Capital Market under the symbol CELU while the company works to regain compliance.
What happens if Celularity (CELU) does not regain compliance by January 19, 2027?
If Celularity does not regain compliance by January 19, 2027, it may qualify for an additional 180-day grace period if it meets all initial Nasdaq Capital Market listing standards other than the bid price requirement.
Can Celularity (CELU) be sure it will stay listed on Nasdaq?
The company states there is no assurance it will regain compliance during the 180-day period, obtain a second 180-day extension, or continue to meet other Nasdaq listing requirements, leaving delisting a potential risk.